Tumor suppressor DLC-1 induces apoptosis and inhibits the growth and invasion of colon cancer cells through the Wnt/β-catenin signaling pathway

Oncology Reports

Volumn 31, Issue 5, 2014, Pages 2270-2278

  Wang, Chunyi ^a   Wang, Jialin ^a   Liu, Hong ^a   Fu, Zhongxue ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Colorectal cancer; DLC 1; Invasion; Migration; Proliferation; Tumor suppressor gene; Wnt catenin

Indexed keywords

BETA CATENIN; DELETED IN LIVER CANCER 1 PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; MYC PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; WNT PROTEIN; CTNNB1 PROTEIN, HUMAN; DLC1 PROTEIN, HUMAN; GLYCOGEN SYNTHASE KINASE 3; GLYCOGEN SYNTHASE KINASE 3 BETA; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; MYC PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; CELL INVASION ASSAY; CELL MIGRATION ASSAY; CELL PROLIFERATION ASSAY; COLON CANCER; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE COURSE; DLC 1 GENE; DOWN REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MIGRATION INHIBITION; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; UPREGULATION; WESTERN BLOTTING; WNT SIGNALING PATHWAY; BIOSYNTHESIS; CELL MOTION; CELL PROLIFERATION; COLON TUMOR; G1 PHASE CELL CYCLE CHECKPOINT; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; METABOLISM; PATHOLOGY; PROCEDURES; TUMOR CELL LINE; TUMOR INVASION;

APOPTOSIS; BETA CATENIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COLONIC NEOPLASMS; G1 PHASE CELL CYCLE CHECKPOINTS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GENETIC VECTORS; GLYCOGEN SYNTHASE KINASE 3; GTPASE-ACTIVATING PROTEINS; HUMANS; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-MYC; TRANSFECTION; TUMOR SUPPRESSOR PROTEINS; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84898651814     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2014.3057     Document Type: Article

References (37)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics, 2013. CA Cancer J Clin 63: 11-30, 2013
2. Moghimi-Dehkordi B and Safaee A: An overview of colorectal cancer survival rates and prognosis in Asia. World J Gastrointest Oncol 4: 71-75, 2012
3. Arasaradnam RP, Commane DM, Bradburn D and Mathers JC: A review of dietary factors and its influence on DNA methylation in colorectal carcinogenesis. Epigenetics 3: 193-198, 2008
4. Beggs AD and Hodgson SV: The genomics of colorectal cancer: State of the art. Curr Genomics 9: 1-10, 2008
5. Fearon ER: Molecular genetics of colorectal cancer. Ann Rev Pathol 6: 479-507, 2011
6. Worthley DL and Leggett BA: Colorectal cancer: Molecular features and clinical opportunities. Clin Biochem Rev 31: 31-38, 2010
7. Yuan BZ, Miller MJ, Keck CL, Zimonjic DB, Thorgeirsson SS and Popescu NC: Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res 58: 2196-2199, 1998
8. Nagase T, Kikuno R, Hattori A, Kondo Y, Okumura K and Ohara O: Prediction of the coding sequences of unidentified human genes. XIX. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res 7: 347-355, 2012
9. Guan M, Zhou X, Soulitzis N, Spandidos DA and Popescu NC: Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: Potential clinical applications. Clin Cancer Res 12: 1412-1419, 2006
10. Durkin ME, Yuan BZ, Zhou X, Zimonjic DB, Lowy DR, Thorgeirsson SS and Popescu NC: DLC-1: A Rho GTPase-activating protein and tumour suppressor. J Cell Mol Med 11: 1185-1207, 2007
11. Feng X, Li C, Liu W, Chen H, Zhou W, Wang L, Zhu B, Yao K, Jiang X and Ren C: DLC-1, a candidate tumor suppressor gene, inhibits the proliferation, migration and tumorigenicity of human nasopharyngeal carcinoma cells. Int J Oncol 42: 1973-1984, 2013
12. Zhang T, Zheng J, Jiang N, Wang G, Shi Q, Liu C and Lu Y: Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma. Cancer Lett 283: 59-67, 2009
13. van Amerongen R and Nusse R: Towards an integrated view of Wnt signaling in development. Development 136: 3205-3214, 2009
14. Jang KY, Kim YN, Bae JS, Chung MJ, Moon WS, Kang MJ, Lee DG and Park HS: Expression of cyclin D1 is associated with ?-catenin expression and correlates with good prognosis in colorectal adenocarcinoma. Transl Oncol 5: 370-378, 2012
15. Lee HK and Jeong SJ: ?-Catenin as a valid molecular target for the development of therapeutic inhibitors. JNBT 2: 29-37, 2005
16. Pritchard CC and Grady WM: Colorectal cancer molecular biology moves into clinical practice. Gut 60: 116-129, 2011
17. Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin 61: 69-90, 2011
18. Sengupta N, Gill KA, MacFie TS, Lai CS, Suraweera N, Mcdonald S and Silver A: Management of colorectal cancer: A role for genetics in prevention and treatment? Pathol Res Pract 204: 469-477, 2008
19. Wu WK, Wang XJ, Cheng AS, Luo MX, Ng SS, To KF, Chan FK, Cho CH, Sung JJ and Yu J: Dysregulation and crosstalk of cellular signaling pathways in colon. Crit Rev Oncol Hematol 86: 251-277, 2013
20. Liao YC and Lo SH: Deleted in liver cancer-1 (DLC-1): A tumor suppressor not just for liver. Int J Biochem Cell Biol 40: 843-847, 2008
21. Wu PP, Jin YL, Shang YF, Jin Z, Wu P and Huang PL: Restoration of DLC1 gene inhibits proliferation and migration of human colon cancer HT29 cells. Ann Clin Lab Sci 39: 263-269, 2009
22. Ullmannova V and Popescu NC: Expression profile of the tumor suppressor genes DLC-1 and DLC-2 in solid tumors. Int J Oncol 29: 1127-1132, 2006
23. Wilson PJ, McGlinn E, Marsh A, Evans T, Arnold J, Wright K, Biden K, Young J, Wainwright B, Wicking C and Chenevix-Trench G: Sequence variants of DLC1 in colorectal and ovarian tumours. Hum Mutat 15: 156-165, 2000
24. Seidler HB, Utsuyama M, Nagaoka S, Takemura T, Kitagawa M and Hirokawa K: Expression level of Wnt signaling components possibly influences the biological behavior of colorectal cancer in different age groups. Exp Mol Pathol 76: 224-233, 2004
25. Doucas H, Garcea G, Neal CP, Manson MM and Berry DP: Changes in the Wnt signalling pathway in gastrointestinal cancers and their prognostic significance. Eur J Cancer 41: 365-379, 2005
26. Zhou X, Thorgeirsson SS and Popescu NC: Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells. Oncogene 23: 1308-1313, 2004
27. Healy KD, Hodgson L, Kim TY, Shutes A, Maddileti S, Juliano RL, Hahn KM, Harden TK, Bang YJ and Der CJ: DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms. Mol Carcinog 47: 326-337, 2008
28. Jin Y, Tian X, Shang Y and Huang P: Inhibition of DLC-1 gene expression by RNA interference in the colon cancer LoVo cell line. Oncol Rep 19: 669-674, 2008
29. Kim PJ, Plescia J, Clevers H, Fearon ER and Altieri DC: Survivin and molecular pathogenesis of colorectal cancer. Lancet 362: 205-209, 2003
30. Wu PP, Su Y, Jin Z, Wu P, Xu JJ and Huang PL: Effects of DLC1 gene transfection on HT29 cell cycle distribution: The role of Rho A. Southeast Univ (Med Sci Edi) 28: 247-251, 2009
31. Clevers H and Nusse R: Wnt/?-catenin signaling and disease. Cell 149: 1192-1205, 2012
32. MacDonald BT, Tamai K and He X: Wnt/?-catenin signaling: Components, mechanisms, and diseases. Dev Cell 7: 9-26, 2009
33. Kimelman D and Xu W: Beta-catenin destruction complex: Insights and questions from a structural perspective. Oncogene 25: 7482-7491, 2006
34. Kawasaki Y, Sato R and Akiyama T: Mutated APC and Asef are involved in the migration of colorectal tumour cells. Nat Cell Biol 5: 211-215, 2003
35. Miyashiro I, Senda T, Matsumine A, Baeg GH, Kuroda T, Shimano T, Miura S, Noda T, Kobayashi S and Monden M: Subcellular localization of the APC protein: Immunoelectron microscopic study of the association of the APC protein with catenin. Oncogene 11: 89-96, 1995
36. van de Wetering M, Sancho E, Verweij C, de Lau W, Oving I, Hurlstone A, van der Horn K, Batlle E, Coudreuse D, Haramis AP, Tjon-Pon-Fong M, Moerer P, van den Born M, Soete G, Pals S, Eilers M, Medema R and Clevers H: The ?-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells. Cell 111: 241-250, 2002
37. Zhang T, Otevrel T, Gao Z, Gao Z, Ehrlich SM, Fields JZ and Boman BM: Evidence that APC regulates survivin expression: A possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res 61: 8664-8667, 2001